What Researchers Did
Researchers conducted a narrative review to explore the mechanisms of hyperbaric oxygen therapy (HBOT) and aerobic exercise in alleviating pain in fibromyalgia.
What They Found
The review highlighted that fibromyalgia affects approximately 1-3% of adults in the US, typically between 40-50 years old. Both hyperbaric oxygen therapy (HBOT) and aerobic exercise demonstrated promising effects in pain management, with HBOT reducing inflammation and influencing neuroplasticity, and exercise offering anti-inflammatory and antioxidant benefits.
What This Means for Canadian Patients
Canadian patients with fibromyalgia may find these insights useful for understanding potential non-pharmacological approaches to pain management. Discussing hyperbaric oxygen therapy or incorporating regular aerobic exercise could be beneficial as part of a comprehensive treatment plan.
Canadian Relevance
This review does not have a direct Canadian connection, as it primarily discusses fibromyalgia prevalence and treatment approaches in a general context, with specific US prevalence mentioned.
Study Limitations
As a narrative review, this study may be limited by its subjective selection of literature and lack of a systematic approach to evidence synthesis.